Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
1.09M
-
Shares change
-
+82K
-
Total reported value, excl. options
-
$105M
-
Value change
-
+$6.74M
-
Number of buys
-
3
-
Number of sells
-
-3
-
Price
-
$96.43
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2023
6 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2023.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.09M shares
of 106M outstanding shares and own 1.03% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.82M shares), BlackRock Inc. (6.21M shares), JANUS HENDERSON GROUP PLC (5.35M shares), Capital International Investors (4.74M shares), Avoro Capital Advisors LLC (4.34M shares), WELLINGTON MANAGEMENT GROUP LLP (4.13M shares), STATE STREET CORP (2.4M shares), Bank of New York Mellon Corp (2.33M shares), T. Rowe Price Investment Management, Inc. (1.92M shares), and FMR LLC (1.51M shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.